Stay updated with breaking news from உயிரியல் லிமிடெட். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biocon s Semglee gets USFDA approval; first interchangeable biosimilar product in US SECTIONS Last Updated: Jul 29, 2021, 09:56 AM IST Share Synopsis “It is a milestone achievement for both Biocon Biologics and our partner Viatris. This will allow pharmacy level substitution and thereby provide convenient and affordable access to Semglee, a quality Biosimilar Insulin Glargine,” Biocon Biologics, Executive Chairperson, Kiran Mazumdar-Shaw said in a statement. The company is eligible to have exclusivity for 12 months before the FDA can approve another biosimilar interchangeable to Lantus. Biocon Biologics Ltd, a unit of Biocon and Viatris Inc said on Thursday that the U.S. Food and Drug Administration (FDA) has approved its insulin glargine-yfgn injection branded Semglee in the US market. ....
Biocon Biologics Partners with Adagio Therapeutics to Advance Antibody for the Prevention and Treatment of COVID-19 equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Supply enough, 200-220 million vaccine doses from July: NK Arora indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Covaxin output may hit 100 million doses per month by November indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
Read more about Why govt delayed emergency approval to coronavirus vaccine: Chidambaram on Business Standard. P Chidambaram accused the central government of needlessly delaying approval to Coronavirus vaccines in the country for many months except in the case of Covaxin, Covishield and Sputnik V ....